TRACX Mutual Fund Forecast & Price Targets

See the Price Targets and Ratings of:

TRACX Analyst Rating

Moderate Buy
446ConsensusRatings
265 Buy
169 Hold
12 Sell
Based on the consensus analyst ratings on 446 stocks held in TRACX.
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

TRACX Analyst Price Target

Average Price Target

$22.09
Based on 446 Wall Street analysts offering 12 month price targets to PGIM QMA Small-Cap Value Fund Class C holdings in the last 3 months. The average price target is $22.09 with a high forecast of $25.32 and a low forecast of $19.34. The average price target represents a 14.56% change from the last price of $19.28.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"14":"$14","17":"$17","20":"$20","23":"$23","26":"$26"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":25.323,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$25.32</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":22.088,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$22.09</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":19.337,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$19.34</span>\n  </div></div>","useHTML":true}}],"tickPositions":[14,17,20,23,26],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Nov<br/>2023","6":"Feb<br/>2024","9":"May<br/>2024","12":"Aug<br/>2024","25":"Aug<br/>2025"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n              \n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.27,19.735615384615386,20.20123076923077,20.666846153846155,21.132461538461538,21.598076923076924,22.063692307692307,22.529307692307693,22.994923076923076,23.460538461538462,23.926153846153845,24.39176923076923,24.857384615384618,{"y":25.323,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.27,19.48676923076923,19.70353846153846,19.92030769230769,20.137076923076922,20.353846153846153,20.570615384615387,20.787384615384617,21.004153846153848,21.22092307692308,21.43769230769231,21.65446153846154,21.87123076923077,{"y":22.088,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,19.27,19.275153846153845,19.28030769230769,19.285461538461536,19.290615384615386,19.29576923076923,19.300923076923077,19.306076923076922,19.311230769230768,19.316384615384614,19.321538461538463,19.32669230769231,19.331846153846154,{"y":19.337,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":17.16,"date":1690848000000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16.84,"date":1693526400000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":15.58,"date":1696204800000,"info":"<div>Price: <b>$16<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":15.03,"date":1698796800000,"info":"<div>Price: <b>$15<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":16.8,"date":1701388800000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.27,"date":1704153600000,"info":"<div>Price: <b>$18<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.63,"date":1706745600000,"info":"<div>Price: <b>$18<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.7,"date":1709251200000,"info":"<div>Price: <b>$18<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.25,"date":1711929600000,"info":"<div>Price: <b>$18<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.36,"date":1714521600000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":18.06,"date":1717372800000,"info":"<div>Price: <b>$18<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":17.48,"date":1719792000000,"info":"<div>Price: <b>$17<b/></div>","marker":{"enabled":true,"symbol":"circle"}},{"y":19.27,"date":1722470400000,"info":"<div>Price: <b>$19<b/></div>","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price Target$25.32Average Price Target$22.09Lowest Price Target$19.34
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

TRACX Stocks With Highest Upside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Sagimet Biosciences, Inc. Class A
5 Buy
1 Hold
0 Sell
Strong Buy
$32.60
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Kezar Life Sciences
2 Buy
1 Hold
0 Sell
Moderate Buy
$4.50
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Adicet Bio Inc
5 Buy
1 Hold
0 Sell
Strong Buy
$9.20
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Caribou Biosciences, Inc.
4 Buy
1 Hold
0 Sell
Strong Buy
$12.75
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Century Therapeutics, Inc.
4 Buy
1 Hold
0 Sell
Strong Buy
$9.00

TRACX Stocks With Highest Downside Potential

Name
Price & Change
Analyst Consensus
Analyst Price Target
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Midwestone Financial
0 Buy
2 Hold
0 Sell
Hold
$23.50
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Re/Max Holdings Inc
0 Buy
2 Hold
2 Sell
Moderate Sell
$9.13
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Washington Trust Bancorp
0 Buy
2 Hold
1 Sell
Moderate Sell
$27.50
xxxxxxxxxxxxxxxxxxxxxxxxxxx
Navient Corporation
0 Buy
5 Hold
2 Sell
Moderate Sell
$14.26
xxxxxxxxxxxxxxxxxxxxxxxxxxx
SL Green Realty Corp
2 Buy
5 Hold
4 Sell
Hold
$56.18

TRACX Mutual Fund FAQ

What is TRACX’s average 12-month price target, according to analysts?
Based on analyst ratings, PGIM QMA Small-Cap Value Fund Class C’s 12-month average price target is $22.09.
    What is TRACX’s upside potential, based on the analysts’ average price target?
    Currently there's no upside potential for TRACX, based on the analysts’ average price target.
    Can I see which stocks the top-ranking analysts are rating?
    Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
      How can I follow the stock ratings of top Wall Street analysts?
      Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
        Is TRACX a Buy, Sell or Hold?
        PGIM QMA Small-Cap Value Fund Class C has a consensus rating of Moderate Buy which is based on 265 buy ratings, 169 hold ratings and 12 sell ratings.
          What is PGIM QMA Small-Cap Value Fund Class C’s price target?
          The average price target for PGIM QMA Small-Cap Value Fund Class C is $22.09. This is based on 446 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
          The highest analyst price target is $25.32 ,the lowest forecast is $19.34. The average price target represents N/A Increase from the current price of N/A.
            What do analysts say about PGIM QMA Small-Cap Value Fund Class C?
            PGIM QMA Small-Cap Value Fund Class C’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 446 Wall Streets Analysts.
              How can I buy shares of TRACX?
              Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis